202 related articles for article (PubMed ID: 10936861)
21. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
22. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H
Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
[TBL] [Abstract][Full Text] [Related]
23. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
Koyama T; Aoki N
Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
[TBL] [Abstract][Full Text] [Related]
24. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
25. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
26. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
27. A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes.
Strandberg K; Bhiladvala P; Holm J; Stenflo J
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):503-10. PubMed ID: 11685037
[TBL] [Abstract][Full Text] [Related]
28. The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
Bremme K; Hamad RR; Berg E; Strandberg K; Stenflo J
Thromb Res; 2012 Oct; 130(4):636-9. PubMed ID: 22154243
[TBL] [Abstract][Full Text] [Related]
29. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
30. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
31. Activation of the protein C pathway in acute sepsis.
Alcaraz A; España F; Sánchez-Cuenca J; Zuazu I; Estellés A; Aznar J; Vicente V
Thromb Res; 1995 Jul; 79(1):83-93. PubMed ID: 7495107
[TBL] [Abstract][Full Text] [Related]
32. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
33. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
34. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients.
Bakoush O; Ohlin AK; Strandberg K; Kurkus J
Nephron Clin Pract; 2008; 110(3):c151-7. PubMed ID: 18953177
[TBL] [Abstract][Full Text] [Related]
35. Elevated fibrin-related markers in patients with malignant diseases suspected of having thrombotic disorders.
Nomura H; Wada H; Mizuno T; Yamashita Y; Saito K; Kitano S; Katayama N; Yamada N; Sugiyama T; Sudo A; Usui M; Isaji S; Nobori T
Clin Appl Thromb Hemost; 2010 Jun; 16(3):266-72. PubMed ID: 19648145
[TBL] [Abstract][Full Text] [Related]
36. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Wada K; Niwano H; Shibata A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
[TBL] [Abstract][Full Text] [Related]
37. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
Watanabe R; Wada H; Watanabe Y; Sakakura M; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Nobori T; Shiku H
Thromb Res; 2001 Oct; 104(1):1-6. PubMed ID: 11583733
[TBL] [Abstract][Full Text] [Related]
38. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
39. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
Koike K; Fujimaki M
Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
[TBL] [Abstract][Full Text] [Related]
40. [Molecular marker for anticoagulant protein C pathway (APC-PCI complex)].
Hamada T; Kamada H; Suzuki K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():674-7. PubMed ID: 15658421
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
